2024 Q2 Form 10-Q Financial Statement

#000172138624000012 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $431.1M $294.0M $241.7M
YoY Change 47.03% 21.64% -23.55%
Cost Of Revenue $367.0M $250.6M $197.8M
YoY Change 51.27% 26.7% -21.23%
Gross Profit $64.18M $43.46M $43.97M
YoY Change 26.68% -1.16% -32.51%
Gross Profit Margin 14.89% 14.78% 18.19%
Selling, General & Admin $54.22M $44.57M $39.19M
YoY Change 22.35% 13.73% -6.1%
% of Gross Profit 84.48% 102.55% 89.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.850M $1.320M $1.418M
YoY Change 62.42% -6.91% -12.63%
% of Gross Profit 2.88% 3.04% 3.22%
Operating Expenses $54.22M $44.57M $39.19M
YoY Change 22.35% 13.73% -6.1%
Operating Profit $9.958M -$1.109M $4.785M
YoY Change 56.89% -123.18% -79.57%
Interest Expense $18.00M $10.60M $4.600M
YoY Change 146.58% 130.43% -28.39%
% of Operating Profit 180.76% 96.13%
Other Income/Expense, Net -$5.353M $1.813M $955.0K
YoY Change -561.86% 89.84% 261.74%
Pretax Income $4.605M $704.0K $5.740M
YoY Change -38.65% -87.74% -68.34%
Income Tax $1.400M -$30.00K $1.617M
% Of Pretax Income 30.4% -4.26% 28.17%
Net Earnings $2.885M $190.0K $3.218M
YoY Change -41.68% -94.1% -75.37%
Net Earnings / Revenue 0.67% 0.06% 1.33%
Basic Earnings Per Share $0.08 $0.01 $0.08
Diluted Earnings Per Share $0.08 $0.01 $0.08
COMMON SHARES
Basic Shares Outstanding 36.18M shares 36.13M shares 39.98M shares
Diluted Shares Outstanding 36.37M shares 36.80M shares 40.12M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $82.15M $121.5M $136.8M
YoY Change 10.74% -11.18% 77.97%
Cash & Equivalents $82.15M $121.5M $136.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.350B $1.197B $1.081B
Prepaid Expenses
Receivables $2.600M $3.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.435B $1.321B $1.218B
YoY Change 19.65% 8.49% 0.39%
LONG-TERM ASSETS
Property, Plant & Equipment $24.90M $13.80M
YoY Change 80.43%
Goodwill $152.3M $68.64M $68.64M
YoY Change 121.92% 0.0% -2.28%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.07M $18.46M $2.760M
YoY Change 1164.23% 568.84% -82.63%
Total Long-Term Assets $308.0M $222.3M $210.4M
YoY Change 48.59% 5.64% 74.16%
TOTAL ASSETS
Total Short-Term Assets $1.435B $1.321B $1.218B
Total Long-Term Assets $308.0M $222.3M $210.4M
Total Assets $1.743B $1.543B $1.428B
YoY Change 23.91% 8.07% 7.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $95.47M $88.71M $62.47M
YoY Change 30.96% 41.99% -16.94%
Accrued Expenses $219.6M $191.9M $135.2M
YoY Change 58.6% 41.97% 37.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $315.9M $281.5M $198.5M
YoY Change 48.86% 41.79% 2.82%
LONG-TERM LIABILITIES
Long-Term Debt $754.1M $585.2M $516.9M
YoY Change 56.22% 13.2% 4.56%
Other Long-Term Liabilities $0.00 $200.0K
YoY Change -100.0%
Total Long-Term Liabilities $754.1M $585.4M $516.9M
YoY Change 56.22% 13.24% 1.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $315.9M $281.5M $198.5M
Total Long-Term Liabilities $754.1M $585.4M $516.9M
Total Liabilities $1.070B $866.9M $715.5M
YoY Change 42.8% 21.16% 1.73%
SHAREHOLDERS EQUITY
Retained Earnings $190.7M $187.8M $161.6M
YoY Change 14.5% 16.22% 65.1%
Common Stock $460.0M $459.5M $496.7M
YoY Change -6.26% -7.48% -6.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $650.7M $647.3M $658.3M
YoY Change
Total Liabilities & Shareholders Equity $1.743B $1.543B $1.428B
YoY Change 23.91% 8.07% 7.07%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $2.885M $190.0K $3.218M
YoY Change -41.68% -94.1% -75.37%
Depreciation, Depletion And Amortization $1.850M $1.320M $1.418M
YoY Change 62.42% -6.91% -12.63%
Cash From Operating Activities $33.64M -$33.24M $5.477M
YoY Change -299.14% -706.81% -117.04%
INVESTING ACTIVITIES
Capital Expenditures $1.712M $1.907M $1.563M
YoY Change -14.74% 22.01% -202.76%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$235.0M $0.00
YoY Change -100.0%
Cash From Investing Activities -$236.8M -$1.907M -$1.563M
YoY Change 11690.59% 22.01% -99.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 163.8M $37.08M $9.237M
YoY Change -474.78% 301.42% -66.18%
NET CHANGE
Cash From Operating Activities 33.64M -$33.24M $5.477M
Cash From Investing Activities -236.8M -$1.907M -$1.563M
Cash From Financing Activities 163.8M $37.08M $9.237M
Net Change In Cash -39.34M $1.937M $13.15M
YoY Change -37.15% -85.27% -104.94%
FREE CASH FLOW
Cash From Operating Activities $33.64M -$33.24M $5.477M
Capital Expenditures $1.712M $1.907M $1.563M
Free Cash Flow $31.92M -$35.14M $3.914M
YoY Change -268.92% -997.85% -112.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294041000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
241740000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
250580000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
197767000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
43461000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
43973000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18488000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16408000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26082000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22780000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
44570000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
39188000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1109000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4785000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1813000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
955000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
704000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5740000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-30000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1617000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
734000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4123000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
544000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
905000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
190000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3218000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36279679 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39997699 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36798722 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40116873 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
688352000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
736000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
674000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
678000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6509000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6793000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
734000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
676524000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
710319000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
550000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-361000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
913000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4123000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
712618000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
734000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4123000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1320000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1418000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
678000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-361000 usd
CY2024Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
256000 usd
CY2023Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
115000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-183000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
580000 usd
CY2024Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-30631000 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-14341000 usd
CY2024Q1 lhi Increase Decrease In Real Estate Inventories
IncreaseDecreaseInRealEstateInventories
50929000 usd
CY2023Q1 lhi Increase Decrease In Real Estate Inventories
IncreaseDecreaseInRealEstateInventories
-13184000 usd
CY2024Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
114000 usd
CY2023Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
307000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
20298000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2232000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10738000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11972000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6068000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13412000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33235000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5477000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1907000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1563000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1907000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1563000 usd
CY2024Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
117654000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
175000000 usd
CY2024Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
65000000 usd
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
164300000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
675000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
550000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
736000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6452000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
6793000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
913000 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2324000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
67000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37079000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9237000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1937000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13151000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119555000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123634000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121492000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136785000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span>—The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.
CY2024Q1 lhi Inventory Real Estate Deposits And Pre Acquisition Costs
InventoryRealEstateDepositsAndPreAcquisitionCosts
122237000 usd
CY2023Q4 lhi Inventory Real Estate Deposits And Pre Acquisition Costs
InventoryRealEstateDepositsAndPreAcquisitionCosts
99702000 usd
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
268829000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
272825000 usd
CY2024Q1 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
744261000 usd
CY2023Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
692126000 usd
CY2024Q1 lhi Inventory Real Estate Model Homes
InventoryRealEstateModelHomes
61179000 usd
CY2023Q4 lhi Inventory Real Estate Model Homes
InventoryRealEstateModelHomes
57073000 usd
CY2024Q1 us-gaap Inventory Real Estate
InventoryRealEstate
1196506000 usd
CY2023Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1121726000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
15300000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
11900000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
10600000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
4600000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3100000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
400000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1100000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
200000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
200000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
48949000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
46657000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1736000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
911000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1584000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1338000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
49101000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
46230000 usd
CY2024Q1 lhi Lessee Operating Lease Option To Extend Number
LesseeOperatingLeaseOptionToExtendNumber
1 extension
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13800000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14900000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11900000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13100000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2492000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2710000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2554000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2768000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2384000 usd
CY2024Q1 lhi Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4958000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17866000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2973000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14893000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.043
CY2024Q1 lhi Number Of Geographic Regions
NumberOfGeographicRegions
6 segment
CY2024Q1 lhi Number Of Geographic Regions
NumberOfGeographicRegions
6 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294041000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
241740000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
704000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5740000 usd
CY2024Q1 us-gaap Assets
Assets
1543377000 usd
CY2023Q4 us-gaap Assets
Assets
1471232000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
39997699 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
236703 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
119174 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36798722 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41500000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36100000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15525000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
190000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3218000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36279679 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40116873 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000 shares
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
378000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 lhi Change In Right Of Use Assets For New Modified Or Terminated Operating Leases
ChangeInRightOfUseAssetsForNewModifiedOrTerminatedOperatingLeases
2553000 usd
CY2023Q1 lhi Change In Right Of Use Assets For New Modified Or Terminated Operating Leases
ChangeInRightOfUseAssetsForNewModifiedOrTerminatedOperatingLeases
-837000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001721386-24-000012-index-headers.html Edgar Link pending
0001721386-24-000012-index.html Edgar Link pending
0001721386-24-000012.txt Edgar Link pending
0001721386-24-000012-xbrl.zip Edgar Link pending
exhibit311-certificationx2.htm Edgar Link pending
exhibit312-certificationx2.htm Edgar Link pending
exhibit321-certificationx2.htm Edgar Link pending
exhibit322-certificationx2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
indemnificationagreement-h.htm Edgar Link pending
lhi-20240331.htm Edgar Link pending
lhi-20240331.xsd Edgar Link pending
lsea-fourthamendedandresta.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lhi-20240331_cal.xml Edgar Link unprocessable
lhi-20240331_def.xml Edgar Link unprocessable
lhi-20240331_lab.xml Edgar Link unprocessable
lhi-20240331_pre.xml Edgar Link unprocessable
lhi-20240331_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending